COMMENTARY

• Predicting Clinical, Financial Impact of Hemophilia Gene Therapy in Japan
  November 7, 2023

• Reform Proposal Signals Perception Gap between Industry, Govt on Purpose of Market Expansion Re-Pricing
  October 31, 2023

• With 2nd Strategy Penned, Can Japan Play Catch-Up with US & Europe in SaMD Push?
  October 3, 2023

• Hopes to Nix Budget Ceiling Dashed, How Will Industry Get Its Message Across to Govt?
  September 4, 2023

• Chuikyo Embracing Industry Opinions in Early Phase of Drug Pricing Debate
  August 29, 2023

• Can “G1” Withdrawal Scheme Be Improved Enough to Serve Its Purpose?
  August 23, 2023

• Study Group of LDP Heavyweights Eyes “Drug Discovery Agency”
  August 7, 2023

• Expert Panel Report Failed to Delve into Annual Price Cuts, Irking Pharma Officials
  June 30, 2023

• Honebuto Policy Is Tailwind for Pharma, but Situation Remains Unpredictable
  June 22, 2023

• Will Wegovy Lead the Way in Changing Picture of Obesity Treatment in Japan?
  May 23, 2023

• Will Bill to Amend Medical Infrastructure Law Accelerate Drug Discovery for Rare Diseases?
  April 28, 2023

• Some Pharma Makers Leery of Further Cut into Off-Patent Brands in Japan
  April 3, 2023

• Revision of Guidelines on Drone Drug Deliveries Expected by March-End: Will Powerful Meds Be OK'ed?
  March 17, 2023

• FY2024 Pricing Reform Likely to Focus on “Balance” between Rewarding Innovation and Optimizing LLP Prices
  February 6, 2023

• LDP Expects to Finalize Tax Reform Plan This Week; Will It Expand R&D Credit System?
  December 13, 2022

• Japan Should Hone Emergency Approval Scheme Based on Xocova Example
  November 28, 2022

• Pharma Industry Stays Pat on “No” to Off-Year Plan, Why Not Going for Trade-Off?
  November 22, 2022

• Pharma Industry Faces Hurdles in Getting Medical Circle to Accept Softer Drug Price Cut Plan
  September 28, 2022

• Delving into Potential Implications of Envisaged Price Revision Overhaul
  September 12, 2022

• Generic Industry Has High Hopes on New Expert Panel; Will Its Recommendations Ease Impact of Annual Re-Pricing?
  September 9, 2022

ページ